Brokerages forecast that Trupanion, Inc. (NASDAQ:TRUP) will post $65.60 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Trupanion’s earnings, with the highest sales estimate coming in at $65.90 million and the lowest estimate coming in at $65.30 million. Trupanion reported sales of $51.34 million in the same quarter last year, which would suggest a positive year over year growth rate of 27.8%. The company is scheduled to report its next earnings results on Tuesday, February 13th.
According to Zacks, analysts expect that Trupanion will report full-year sales of $65.60 million for the current financial year, with estimates ranging from $241.40 million to $242.00 million. For the next fiscal year, analysts forecast that the business will report sales of $295.10 million per share, with estimates ranging from $291.70 million to $298.50 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Trupanion.
Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Thursday, November 2nd. The financial services provider reported $0.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.04. The company had revenue of $63.12 million during the quarter, compared to analyst estimates of $61.44 million. Trupanion had a negative return on equity of 7.41% and a negative net margin of 1.05%. The firm’s quarterly revenue was up 30.5% on a year-over-year basis. During the same quarter last year, the company earned ($0.06) earnings per share.
In other news, insider Darryl Rawlings sold 3,500 shares of the business’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $34.08, for a total value of $119,280.00. Following the completion of the sale, the insider now owns 1,386,476 shares of the company’s stock, valued at approximately $47,251,102.08. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Ian Moffat sold 7,000 shares of the business’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $30.06, for a total value of $210,420.00. Following the completion of the sale, the chief operating officer now directly owns 7,000 shares of the company’s stock, valued at approximately $210,420. The disclosure for this sale can be found here. In the last three months, insiders sold 25,539 shares of company stock valued at $780,673. 31.24% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. bought a new stake in shares of Trupanion in the 3rd quarter valued at about $143,000. Voya Investment Management LLC bought a new stake in shares of Trupanion in the 2nd quarter valued at about $215,000. Oppenheimer Asset Management Inc. purchased a new position in Trupanion during the 3rd quarter valued at about $221,000. Wells Fargo & Company MN increased its holdings in Trupanion by 13.5% during the 2nd quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock valued at $252,000 after purchasing an additional 1,342 shares during the period. Finally, Nationwide Fund Advisors increased its holdings in Trupanion by 52.7% during the 2nd quarter. Nationwide Fund Advisors now owns 12,694 shares of the financial services provider’s stock valued at $284,000 after purchasing an additional 4,380 shares during the period. 63.25% of the stock is owned by institutional investors.
Shares of Trupanion (NASDAQ TRUP) opened at $33.76 on Monday. The stock has a market capitalization of $1,010.00, a price-to-earnings ratio of -375.11 and a beta of 0.14. Trupanion has a 52 week low of $13.88 and a 52 week high of $35.07. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.87 and a current ratio of 1.87.
COPYRIGHT VIOLATION NOTICE: “Analysts Anticipate Trupanion, Inc. (TRUP) Will Post Quarterly Sales of $65.60 Million” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://stocknewstimes.com/2018/01/22/analysts-anticipate-trupanion-inc-trup-will-post-quarterly-sales-of-65-60-million.html.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.